A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing...

Area of Science:

• Global Health
• Infectious Diseases
• Antimicrobial Resistance

Background:

• The 10/90 Gap highlights underfunded research for diseases prevalent in low-income countries.
• Antibiotic-resistant infections pose significant threats to healthcare and economies in developing nations.
• The global antibiotic resistance crisis exacerbates unmet medical needs in these regions.

Purpose of the Study:

• To review the potential of bacteriophage therapy as an alternative treatment for bacterial infections in developing countries.
• To discuss how phage therapy can overcome economic barriers to accessing effective medicines.
• To explore the feasibility of implementing phage therapy in resource-limited settings.

Main Methods:

• Review of existing clinical experience and research in bacteriophage therapy.
• Analysis of clinical trial data related to phage therapy efficacy.
• Discussion of phage sourcing and processing in local contexts.

Main Results:

• Phage therapy presents a viable and economically accessible alternative to traditional antimicrobials.
• Local sourcing and processing of phages can reduce treatment costs.
• Phage therapy shows promise in reducing the burden of key bacterial infections in developing countries.

Conclusions:

• Bacteriophage therapy is a promising, cost-effective strategy to combat antibiotic resistance in developing countries.
• Implementing phage therapy can address critical healthcare needs and improve access to treatment.
• Further research and clinical trials are essential to fully realize the potential of phage therapy globally.